Carregant...
miRNAs as Biomarkers in Chronic Myelogenous Leukemia
[Table: see text] Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm that is frequently characterized by the constitutive expression of the oncogenic protein BCR-ABL tyrosine kinase. Tyrosine kinase inhibitors (TKIs) targeting breakpoint cluster region-ABL are the first-line therapy...
Guardat en:
| Publicat a: | Drug Dev Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758911/ https://ncbi.nlm.nih.gov/pubmed/26284455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21266 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|